Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs

S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

NCT00005089 ·Status: COMPLETED ·Phase: PHASE2

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

NCT07059741 ·Status: RECRUITING ·Phase: NA

Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET

NCT00188149 ·Status: UNKNOWN ·Phase: PHASE4

HD16 for Early Stage Hodgkin Lymphoma

NCT00736320 ·Status: UNKNOWN ·Phase: PHASE3

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00278408 ·Status: COMPLETED ·Phase: PHASE3

Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma

NCT00903890 ·Status: COMPLETED

Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma

NCT04882163 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma

NCT06916416 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma

NCT02449265 ·Status: RECRUITING ·Phase: PHASE3

Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)

NCT06170216 ·Status: ACTIVE_NOT_RECRUITING

Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma

NCT05179213 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

NCT00169169 ·Status: TERMINATED ·Phase: PHASE3

Rituximab and ABVD for Hodgkin's Patients

NCT00504504 ·Status: COMPLETED ·Phase: PHASE2

ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma

NCT06149390 ·Status: COMPLETED

Radiotherapy in Primary Mediastinal Lymphoma

NCT01230008 ·Status: COMPLETED

Rituximab Combined With Chidamide and Lenalidomide for r/r AITL

NCT04319601 ·Status: UNKNOWN ·Phase: NA

A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).

NCT00301314 ·Status: COMPLETED

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

NCT01448096 ·Status: COMPLETED ·Phase: PHASE2

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

NCT00355199 ·Status: COMPLETED ·Phase: PHASE3

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

NCT04028440 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma

NCT00509184 ·Status: COMPLETED ·Phase: PHASE2

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

NCT04480125 ·Status: UNKNOWN ·Phase: PHASE2

Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.

NCT04621604 ·Status: TERMINATED ·Phase: NA

Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma

NCT00834951 ·Status: COMPLETED ·Phase: PHASE2

Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma

NCT03664323 ·Status: COMPLETED